Prosecution Insights
Prosecution Insights
4 pending office actions • 4 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 2 (50%) |
| Double-patenting + other | 1 (25%) |
| Multi-statute (no §101) | 1 (25%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MOU, LIYUAN | 1 | 43.5% | +57.7% |
| DEKARSKE, MADELINE MCGUIRE | 1 | 0.0% | +0.0% |
| MCMILLIAN, KARA RENITA | 1 | 30.4% | +37.9% |
| RODRIGUEZ-GARCIA, VALERIE | 1 | 68.8% | +31.9% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18684205 | 1, 4-OXAZEPANE DERIVATIVES AND USES THEREOF | MOU, LIYUAN | — |
| 18292360 | POLYMORPHIC FORMS OF AURORA A SELECTIVE INHIBITORS AND USES THEREOF | DEKARSKE, MADELINE MCGUIRE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18283834 | NOVEL COMPOUNDS USEFUL AS STING AGONISTS AND USES THEREOF | RODRIGUEZ-GARCIA, VALERIE | 60d |
| 18684205 | 1, 4-OXAZEPANE DERIVATIVES AND USES THEREOF | MOU, LIYUAN | — |
| 18284897 | NOVEL COMPOUNDS USEFUL AS STING AGONISTS AND USES THEREOF | MCMILLIAN, KARA RENITA | — |
| Art Unit | Apps |
|---|---|
| 1628 | 1 |
| 1622 | 1 |
| 1623 | 1 |
| 1621 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18684205 | 1, 4-OXAZEPANE DERIVATIVES AND USES THEREOF | MOU, LIYUAN | 1628 | §103§112 | Non-Final OA | — | Pending | Feb 16, 2024 |
| 18292360 | POLYMORPHIC FORMS OF AURORA A SELECTIVE INHIBITORS AND USES THEREOF | DEKARSKE, MADELINE MCGUIRE | 1622 | §103DP | Non-Final OA | — | Pending | Jan 26, 2024 |
| 18284897 | NOVEL COMPOUNDS USEFUL AS STING AGONISTS AND USES THEREOF | MCMILLIAN, KARA RENITA | 1623 | §112 | Non-Final OA | — | Pending | Sep 29, 2023 |
| 18283834 | NOVEL COMPOUNDS USEFUL AS STING AGONISTS AND USES THEREOF | RODRIGUEZ-GARCIA, VALERIE | 1621 | §112 | Non-Final OA | 60d | Pending | Sep 25, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial